DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $467,669 | +3.4% | 1,885 | 0.0% | 0.10% | +11.4% |
| Q2 2023 | $452,400 | -4.8% | 1,885 | 0.0% | 0.09% | -8.3% |
| Q1 2023 | $475,095 | -5.0% | 1,885 | 0.0% | 0.10% | -17.2% |
| Q4 2022 | $500,317 | -8.7% | 1,885 | -11.2% | 0.12% | -8.7% |
| Q3 2022 | $548,000 | 0.0% | 2,123 | -1.8% | 0.13% | +5.0% |
| Q2 2022 | $548,000 | -12.0% | 2,162 | +1.8% | 0.12% | 0.0% |
| Q1 2022 | $623,000 | -10.7% | 2,123 | 0.0% | 0.12% | -11.7% |
| Q4 2021 | $698,000 | -2.9% | 2,123 | -10.2% | 0.14% | -8.1% |
| Q3 2021 | $719,000 | +13.4% | 2,363 | 0.0% | 0.15% | -18.1% |
| Q2 2021 | $634,000 | +19.2% | 2,363 | 0.0% | 0.18% | +34.8% |
| Q1 2021 | $532,000 | +1.3% | 2,363 | 0.0% | 0.14% | -6.2% |
| Q4 2020 | $525,000 | -1.5% | 2,363 | -4.4% | 0.14% | -29.1% |
| Q3 2020 | $533,000 | +22.0% | 2,473 | 0.0% | 0.20% | +14.0% |
| Q2 2020 | $437,000 | +73.4% | 2,473 | -16.1% | 0.18% | +40.2% |
| Q3 2015 | $252,000 | -0.4% | 2,949 | -0.3% | 0.13% | -22.6% |
| Q2 2015 | $253,000 | +0.8% | 2,957 | 0.0% | 0.16% | -7.3% |
| Q1 2015 | $251,000 | -42.8% | 2,957 | -42.2% | 0.18% | -39.6% |
| Q4 2014 | $439,000 | -3.3% | 5,117 | -14.3% | 0.29% | -7.3% |
| Q3 2014 | $454,000 | -3.4% | 5,969 | 0.0% | 0.32% | -2.8% |
| Q2 2014 | $470,000 | +4.9% | 5,969 | 0.0% | 0.32% | -10.5% |
| Q1 2014 | $448,000 | -2.8% | 5,969 | 0.0% | 0.36% | -5.5% |
| Q4 2013 | $461,000 | -0.9% | 5,969 | -11.0% | 0.38% | -3.3% |
| Q3 2013 | $465,000 | +9.4% | 6,708 | 0.0% | 0.40% | +4.7% |
| Q2 2013 | $425,000 | – | 6,708 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |